Hi HAE12, good question which I'll try and reply...
Not really an uneasiness about the process - I believe it works in principal - the Millipore study, Dr Khalpey's cardiac study etc tells me that there's something to it. Can it be improved or made safer/less manipulative, probably and I think that's what's happening now, especially with the news of the sonification flask/reactor)
I believe the PPS is so low because of poor management (although I don't believe the Doc made deliberate choices to damage the company)- he made a couple of poor investment decisions which have had a big knock-on effect.
I think the other big issue with the PPS is that it was in a position where it could be manipulated down quite easily by others (we probably know who they are but proving it is much more difficult) and it will take a number of big PRs to get it moving up again, passed the point where it can be dropped back down to current levels.
The silence, historically they've been quiet and filed late but that's not a problem as long as they do file - late filing doesn't mean there's nothing to say, just poor management...
Remember they didn't have to have those annual reports redone at cost to the company did they, unless it was to satisfy potential investors.
We don't know that there aren't investors already lined up, terms agreed just waiting to sign on the dotted line, once Andrews/FDA reports are released. If I were an investor, I would tie in the terms of any agreement NOW before these reports are published - it gives me a stronger hand to negotiate with, rather than wait until things improve and there are more investors lining up, all jostling to get in on the act.
Why would they increase the AS and preferred shares if there were no investors sniffing around, that's the only logical reason to increase to 250Bn, that level has no relevance to CDs. (By the way I don't think a RS is on the cards YET)
As I've said on more than one occasion, I think there are too many examples where this extraction process has worked AND produced significant results for it to be BS (think cardiac study, orthopeadic cases, MS case, ALS with Dr Trujillo's sister, head injury cases with military veterans and the list goes on).
Why are there a number of different INDs in the pipeline? Why are Andrews/Invigorcell/Trujillo interested if this is a POS - they have too much of a reputation to lose?
Am is frustrated at the lack of progress, YES, but I believe it will come out in the end and I'm going to be around when it does...
Thoughts???
